International Health Management Association
IHMA supports all phases of anti-infective therapy development, from discovery through commercialization. They are a global antimicrobial partner providing central, reference, and clinical research laboratory services worldwide, with a focus on antimicrobial drug development, surveillance, and clinical trials. IHMA employs state-of-the-art technology and offers customized services to ensure successful drug development, commercialization, and post-marketing pathways.
Industries
Nr. of Employees
medium (51-250)
International Health Management Association
Services
Central laboratory microbiology services
On-site CAP-accredited, CLIA-certified laboratory services for specimen processing, culture, identification, susceptibility testing, and molecular characterization to generate regulatory-ready clinical microbiology data.
Antimicrobial resistance surveillance studies
Design and execution of multi-region surveillance programs to monitor susceptibility trends and provide long-term datasets for regulatory submissions and medical education.
Curated bacterial repository and custom panel assembly
Access to a continuously expanding, catalogued collection of phenotypically and genotypically characterized isolates and the ability to assemble custom panels by specified criteria.
Specialized microbiology laboratory studies
Custom laboratory studies including bacterial killing, resistance development, drug–drug interaction studies, and quality-control guideline development to support discovery and regulatory filing needs.
Clinical scientific expertise and regulatory reporting
Integrated scientific support offering study design consultation, data analysis, preparation of regulatory-ready reports, and authorship support for scientific publications and presentations.
Antimicrobial Voluntary Evaluation Program (RUO material distribution)
Distribution of research-use-only reagents and materials (drug powders, disks, MIC strips, microdilution panels) to local laboratories to enable early testing of newly launched products prior to commercial diagnostic availability.
Central laboratory microbiology services
On-site CAP-accredited, CLIA-certified laboratory services for specimen processing, culture, identification, susceptibility testing, and molecular characterization to generate regulatory-ready clinical microbiology data.
Antimicrobial resistance surveillance studies
Design and execution of multi-region surveillance programs to monitor susceptibility trends and provide long-term datasets for regulatory submissions and medical education.
Curated bacterial repository and custom panel assembly
Access to a continuously expanding, catalogued collection of phenotypically and genotypically characterized isolates and the ability to assemble custom panels by specified criteria.
Specialized microbiology laboratory studies
Custom laboratory studies including bacterial killing, resistance development, drug–drug interaction studies, and quality-control guideline development to support discovery and regulatory filing needs.
Clinical scientific expertise and regulatory reporting
Integrated scientific support offering study design consultation, data analysis, preparation of regulatory-ready reports, and authorship support for scientific publications and presentations.
Antimicrobial Voluntary Evaluation Program (RUO material distribution)
Distribution of research-use-only reagents and materials (drug powders, disks, MIC strips, microdilution panels) to local laboratories to enable early testing of newly launched products prior to commercial diagnostic availability.
Expertise Areas
- Antimicrobial resistance surveillance
- Central laboratory microbiology for clinical trials
- Antimicrobial susceptibility testing
- Molecular diagnostics and genotyping
Key Technologies
- Antimicrobial susceptibility testing (broth microdilution, MIC panels, disk diffusion, MIC strips)
- Molecular diagnostics and genotypic characterization
- Culture and organism identification workflows
- Curated isolate biorepository and custom panels